Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    DN.TO Gross Margin

    As of 2025-07-13, the Gross Margin of Delta 9 Cannabis Inc (DN.TO) is 25.3%.

    Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

    DN.TO Gross Margin - Historical Value
    DateValue
    2023-12-31 25.3%
    2022-12-31 20.4%
    2021-12-31 29.3%
    2020-12-31 34.3%
    2019-12-31 27.4%
    2018-12-31 26.6%
    2017-12-31 34%
    2017-03-31 -
    2016-03-31 -
    2015-03-31 -
    DN.TO Gross Margin - Peers Comparison
    TickerNameValue
    AIDAAida Pharmaceuticals Inc50.3%
    AOXGAoxing Pharmaceutical Company Inc75.9%
    CPH.TOCipher Pharmaceuticals Inc72.2%
    CPHIChina Pharma Holdings Inc-43.8%
    CPIXCumberland Pharmaceuticals Inc82.6%
    CPTR.CNCaptor Capital Corp46.1%
    CSI.CNChemesis International Inc22.4%
    EAT.CNNutritional High International Inc2259%
    EMMAEmmaus Life Sciences Inc92.8%
    GGB.CNGreen Growth Brands Inc-8.5%
    HBMKHubei Minkang Pharmaceutical Ltd42.7%
    ISOL.CNIsodiol International Inc33.2%
    MJAR.CNMJardin Group Inc16.2%
    PLUS.CNPlus Products Inc35.4%
    RTI.VRadient Technologies Inc5.2%
    RX.VBiosyent Inc79.5%
    SHWZMedicine Man Technologies Inc44.1%
    SNOASonoma Pharmaceuticals Inc38.3%
    SUWNSunwin Stevia International Inc8.8%
    SYVCSynovics Pharmaceuticals Inc34.6%
    TBETTibet Pharmaceuticals Inc50%
    TIUM.U.CNCansortium Inc63.9%
    UPCUniverse Pharmaceuticals Inc31.9%
    VEXT.CNVext Science Inc33.1%
    VIVO.TOVivo Cannabis Inc0.5%
    Tickers added to watchlist